People who took both Zepbound and an anti-inflammatory drug saw a greater improvement of their psoriatic arthritis symptoms.

Combination therapy with ixekizumab and tirzepatide bested monotherapy with ixekizumab alone in both psoriatic arthritis and ...

Eli Lilly said Thursday that adding its weight loss drug Zepbound on top of its immunology therapy Taltz helped obese ...

Eli Lilly said on Thursday a late-stage trial showed its weight-loss drug Zepbound, used with its psoriatic arthritis ...

When it comes to taking psoriatic arthritis medication, following your doctor’s instructions to a T is essential for good health. Not taking medication as prescribed can cause symptoms to worsen and ...

Editor’s note: This is an automatically generated transcript, which has been slightly edited for clarity. Please notify [email protected] if there are concerns regarding accuracy of the transcription.

In an open-label phase 3b trial, the co-administration of Lilly’s IL-17A antagonist Taltz (ixekizumab) and dual GIP/GLP-1 ...

Both upadacitinib (Rinvoq) and adalimumab (Humira) are proven effective in rheumatoid arthritis (RA) and psoriatic arthritis ...

Failure to respond to targeted disease-modifying antirheumatic drugs (tsDMARDs) for psoriatic arthritis occurs at an incident rate of about 0.35 per person-year. An observational cohort of 591 ...

Otezla (apremilast) is an oral tablet commonly used to treat psoriatic arthritis in adults. Psoriatic arthritis is a long-lasting condition that affects the joints in people with psoriasis. Common ...

A large US claims analysis links out-of-pocket medication costs with adherence and discontinuation patterns among patients ...

Psoriatic arthritis is a progressive, inflammatory condition that affects your joints and areas of the body where connective tissue meets bone. Because psoriatic arthritis is tied to your immune ...